510(k) Report

510(k) · Cleared

Cleared

Cardio-TriTest v6.5

K182790510(k) SpecialCleared Dec 14, 201874-day reviewClass II21 CFR 870.2340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cardio-Phoenix, Inc. · DPS Electrocardiograph

Cleared on Dec 14, 2018 as substantially equivalent to K143432 (Cardio-Phoenix, Inc., 2015) after a 74-day review. Its family tree reaches back 6 generations to 1994.

Decided
Dec 14, 2018
Review
74 days
Class
Class II
Product code
DPS
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K930806 (1994). 12 ancestors in all, the oldest K910994 (1992). No later device cites it as a predicate yet.

  1. Root · 6 generations backK930806 Zymed Holter Scanner Model 2010Agilent Technologies · 1994
  2. 5 generations backK955015 Zymed Holter Scanner Model 2010Zymed Medical Instrumentation · 1996
  3. 4 generations backK990170 Holter 2000Zymed Medical Instrumentation · 1999
  4. 3 generations backK010949 2010 Plus Holter for WindowsAgilent Technologies · 2001
  5. 2 generations backK031517 Zargis Acoustic CardioscanZargis Medical Corp. · 2004
  6. 1 generation backK143432 Cardio-TriTestCardio-Phoenix, Inc. · 2015
  7. This deviceK182790 Cardio-TriTest v6.5Cardio-Phoenix, Inc. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K930806Zymed Holter Scanner Model 2010Agilent Technologies1994—
−5K955015Zymed Holter Scanner Model 2010Zymed Medical Instrumentation1996—
−4K990170Holter 2000Zymed Medical Instrumentation1999—
−3K0109492010 Plus Holter for WindowsAgilent Technologies2001—
−2K031517Zargis Acoustic CardioscanZargis Medical Corp.2004—
−1K143432Cardio-TriTestCardio-Phoenix, Inc.2015—
0 (this device)K182790Cardio-TriTest v6.5Cardio-Phoenix, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199220
199810
200010
200310
200910
FIG. 1 — Lineage of K182790, 1994–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DPS device

  1. #1 K212112 Cardiologs Holter Platformscore 18.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K143432Cardio-TriTest
Summary page 6
…= K182790 510(k) Summary – Cardio-TriTest v6.5 Legally marketed predicate devices:  Cardio-TriTest v5.5 (k143432) Device Description The Cardio-TriTest v6.5 (CTT) is three devices in one; combining a 12-Lead Electrocardiograph (ECG), a 4 Le…
Cardio-Phoenix, Inc.2015—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 4 companies; a new generation was cleared every 3.1 years on median.
  • None of the 12 ancestors has a recall.

How does its category compare?

All DPS devices

DPS Electrocardiograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · DPS

6in 2025

2007: 112008: 132009: 142010: 112011: 222012: 122013: 102014: 112015: 82016: 112017: 92018: 142019: 32020: 62021: 52022: 62023: 102024: 82025: 62026 (partial year): 6
2007high 22 (2011) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DPS

163in 2025

2007: 87 days median2008: 31 days median2009: 84 days median2010: 104 days median2011: 154 days median2012: 117 days median2013: 134 days median2014: 253 days median2015: 178 days median2016: 229 days median2017: 177 days median2018: 221 days median2019: 178 days median2020: 224 days median2021: 135 days median2022: 244 days median2023: 236 days median2024: 260 days median2025: 163 days median2026 (partial year): 258 days median
2007high 260 (2024) · low 31 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DPS

3in 2025

2007: 22009: 12010: 22011: 12019: 92020: 22021: 12022: 12023: 32024: 4, 1 Class I2025: 32026 (partial year): 4
2007high 9 (2019) · low 0 (2008)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · DPS

55in 2025

2007: 92008: 172009: 142010: 212011: 1212012: 562013: 152014: 152015: 302016: 122017: 152018: 192019: 272020: 592021: 242022: 592023: 542024: 642025: 55
2007high 121 (2011) · low 9 (2007)2025

MAUDE reports naming product code DPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007118729
20081331017
20091484114
201011104221
2011221541121
201212117056
201310134015
201411253015
20158178030
201611229012
20179177015
201814221019
20193178927
20206224259
20215135124
20226244159
202310236354
202482604 (1)64
20256163355
202662584—

What is it indicated for?

The intended use of the device is to acquire and record the 3 different types of heart bio-signals (ECG, PCG, and MCG) and combine the results into a contiguous presentation as an aid to diagnostic interpretation by a Physician in a clinical setting.

The indication for use is as...

a. a Standard 12 Lead Diagnostic ECG

b. an aid to identify events in the cardiac cycle

c. an aid to detect S1 & S2 hearts sounds and murmurs.

Any diagnostic interpretation is only significant when used in conjunction with physician over-read as well as consideration of all other relevant patient data.

The Cardio-TriTest is on a prescription basis by a Certified Medical Practitioner.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K182790: Cardio-TriTest v6.5.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K182790

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026